Search
Patexia Research
Case number 2020-2108

Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. > Documents

Date Field Doc. No.Description (Pages)
Feb 3, 2021 17 Mandate issued to the United States District Court for the District of Nevada. Service as of this date by the Clerk of Court. [753628] [MJL] [Entered: 02/03/2021 11:29 AM] (1)
Dec 28, 2020 16 ORDER filed terminating appeal. The underlying judgment of the United States District Court for the District of Nevada is affirmed consistent with this court's decision in Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc., Appeal Nos. 2020-1723, -1901 (Fed. Cir. Sept. 3, 2020), reh'g and reh'g en banc denied (Nov. 4, 2020). Each side shall bear its own costs. Service as of this date by the Clerk of Court. [745377] [LMS] [Entered: 12/28/2020 10:55 AM] (2)
Nov 25, 2020 15 Status report for Appellants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited and Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 11/25/2020 by email. [738373] [20-2108] [Deanna Reichel] [Entered: 11/25/2020 11:29 AM] (10)
Oct 15, 2020 14 ORDER filed maintaining the stay. Within 14 days after the exhaustion of appeal rights in Appeal Nos. 2020-1723, -1901, the parties are directed to inform the court as to how they believe this case should proceed. Service as of this date by the Clerk of Court. [729118] [LMS] [Entered: 10/15/2020 03:12 PM] (2)
Sep 16, 2020 13 Status report for Appellants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited and Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 09/16/2020 by email. [722155] [20-2108] [Deanna Reichel] [Entered: 09/16/2020 12:25 PM] (9)
Aug 27, 2020 12 ORDER filed denying [10] [11] the motion, and the above-captioned appeal is stayed. Within fourteen days from the court's disposition of Appeal Nos. 2020-1723, -1901, the parties are directed to inform this court as to how this appeal should proceed. A copy of this order and the motion papers shall be transmitted to the merits panel assigned to these cases. Service as of this date by the Clerk of Court. [717950] [LMS] [Entered: 08/27/2020 10:28 AM] (2)
Aug 12, 2020 9 NOTICE OF NON-COMPLIANCE: The submission of Appellants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited and Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc., Motion to consolidate appeals [8], is not in compliance with the rules of this court (see attached). Compliant document due on 08/19/2020. Service as of this date by the Clerk of Court. [714370] [KMH] [Entered: 08/12/2020 10:11 AM] (1)
Aug 12, 2020 10 MOTION of Appellants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited and Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. to consolidate appeals (20-1723) [Consent: unopposed]. Service: 08/12/2020 by email. [714411] [20-2108] [Deanna Reichel] [Entered: 08/12/2020 12:39 PM] (15)
Aug 12, 2020 11 MOTION of Appellants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited and Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. to consolidate appeals (20-1723) [Consent: unopposed]. Service: 08/12/2020 by email. [714414] [20-2108] [Deanna Reichel] [Entered: 08/12/2020 12:49 PM] (21)
Aug 11, 2020 8 MOTION of Appellants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited and Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc. to consolidate appeals (20-1723) [Consent: unopposed]. Service: 08/11/2020 by email. [714224] [20-2108] This document is non-compliant. See Doc No. [9] [Deanna Reichel] [Entered: 08/11/2020 02:53 PM] (13)
Aug 6, 2020 2 Entry of appearance for Jonathan E. Singer; Deanna J. Reichel; Nitika Gupta Fiorella; Oliver Richards; Eric Sonnenschein; Jeffrey Elikan; Christopher Sipes as counsel for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 08/06/2020 by email. [713105] [20-2108] [Jonathan Singer] [Entered: 08/06/2020 03:20 PM] (2)
Aug 6, 2020 3 Certificate of Interest for Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 08/06/2020 by email. [713107] [20-2108] [Jonathan Singer] [Entered: 08/06/2020 03:23 PM] (4)
Aug 6, 2020 4 Docketing Statement for the Appellants Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited. Service: 08/06/2020 by email. [713111] [20-2108] [Jonathan Singer] [Entered: 08/06/2020 03:25 PM] (2)
Aug 6, 2020 5 Entry of appearance for Charles B. Klein; Eimeric Reig-Plessis; Claire A. Fundakowski; Alison M. Heydorn as counsel for Appellees Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals International Limited. Service: 08/06/2020 by email. [713140] [20-2108] [Charles Klein] [Entered: 08/06/2020 04:23 PM] (2)
Aug 6, 2020 6 Docketing Statement for the Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 08/06/2020 by email. [713145] [20-2108] [Charles Klein] [Entered: 08/06/2020 04:28 PM] (2)
Aug 6, 2020 7 Certificate of Interest for Appellees Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 08/06/2020 by email. [713146] [20-2108] [Charles Klein] [Entered: 08/06/2020 04:31 PM] (3)
Aug 3, 2020 1 Appeal docketed. Received: 07/27/2020. [711836]Entry of Appearance is due on 08/17/2020. Certificate of Interest is due on 08/17/2020. Docketing Statement is due on 08/17/2020. Appellant's brief is due on 10/02/2020. [KMH] [Entered: 08/03/2020 11:20 AM] (17)
Menu